DE1934969A1 - Antihaemorrhoidal wirkende Praeparate zur rektalen Anwendung - Google Patents
Antihaemorrhoidal wirkende Praeparate zur rektalen AnwendungInfo
- Publication number
- DE1934969A1 DE1934969A1 DE19691934969 DE1934969A DE1934969A1 DE 1934969 A1 DE1934969 A1 DE 1934969A1 DE 19691934969 DE19691934969 DE 19691934969 DE 1934969 A DE1934969 A DE 1934969A DE 1934969 A1 DE1934969 A1 DE 1934969A1
- Authority
- DE
- Germany
- Prior art keywords
- antihaemorrhoidal
- content
- suppositories
- tri
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 12
- 239000000829 suppository Substances 0.000 claims description 20
- 239000006071 cream Substances 0.000 claims description 18
- 239000002674 ointment Substances 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 9
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 claims description 9
- 229960001747 cinchocaine Drugs 0.000 claims description 8
- 239000003589 local anesthetic agent Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 208000014617 hemorrhoid Diseases 0.000 claims description 3
- ULLNJSBQMBKOJH-VIVFLBMVSA-N (3R,4R,5R)-5-[(1R)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxy-3-oxolanol Chemical compound C([C@H]([C@H]1OC([C@@H]([C@H]1OCC=1C=CC=CC=1)O)OCC)OCC=1C=CC=CC=1)OCC1=CC=CC=C1 ULLNJSBQMBKOJH-VIVFLBMVSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 2
- 235000014347 soups Nutrition 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 13
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- -1 antibiotics Chemical class 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 239000005662 Paraffin oil Substances 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 229940110456 cocoa butter Drugs 0.000 description 3
- 235000019868 cocoa butter Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ULLNJSBQMBKOJH-JPHCZMGXSA-N (2s,3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol Chemical compound C([C@H]([C@H]1O[C@@H]([C@@H]([C@H]1OCC=1C=CC=CC=1)O)OCC)OCC=1C=CC=CC=1)OCC1=CC=CC=C1 ULLNJSBQMBKOJH-JPHCZMGXSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YQKAVWCGQQXBGW-UHFFFAOYSA-N Piperocaine Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=CC=C1 YQKAVWCGQQXBGW-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 150000002398 hexadecan-1-ols Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229960001045 piperocaine Drugs 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003567 tribenoside Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1081768 | 1968-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1934969A1 true DE1934969A1 (de) | 1970-01-22 |
Family
ID=4367170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19691934969 Pending DE1934969A1 (de) | 1968-07-19 | 1969-07-10 | Antihaemorrhoidal wirkende Praeparate zur rektalen Anwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3594473A (enExample) |
| BE (1) | BE736301A (enExample) |
| CA (1) | CA920950A (enExample) |
| CY (1) | CY793A (enExample) |
| DE (1) | DE1934969A1 (enExample) |
| FR (1) | FR2013248A1 (enExample) |
| GB (1) | GB1281719A (enExample) |
| IE (1) | IE33230B1 (enExample) |
| IL (1) | IL32576A (enExample) |
| MY (1) | MY7500089A (enExample) |
| NL (1) | NL6911103A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7713617L (sv) * | 1977-12-01 | 1979-06-02 | Astra Laekemedel Ab | Antitranspirationsmedel |
| JPH0676314B2 (ja) * | 1985-09-30 | 1994-09-28 | 花王株式会社 | 坐剤基剤及び坐剤 |
| US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
| US5869059A (en) * | 1996-01-16 | 1999-02-09 | Mon's Tea Partnership | Herbal composition for hemorrhoid treatment |
| US6365198B1 (en) * | 2001-01-28 | 2002-04-02 | Gulf Pharmaceutical Industries | Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids |
| US20060008536A1 (en) * | 2004-07-08 | 2006-01-12 | Jdc Pharmaceutical | Pharmaceutical compositions and methods of use |
| FR3117442A1 (fr) | 2020-12-15 | 2022-06-17 | Psa Automobiles Sa | Dispositif de fixation d’une aile sur une structure laterale de vehicule automobile |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK126687B (da) * | 1959-01-10 | 1973-08-13 | Ciba Geigy Ag | Analogifremgangsmåde til fremstilling af glucofuranosider eller 2-0-acylderivater deraf. |
-
1969
- 1969-07-08 US US840023A patent/US3594473A/en not_active Expired - Lifetime
- 1969-07-08 CA CA056435A patent/CA920950A/en not_active Expired
- 1969-07-08 IL IL32576A patent/IL32576A/xx unknown
- 1969-07-10 DE DE19691934969 patent/DE1934969A1/de active Pending
- 1969-07-15 IE IE969/69A patent/IE33230B1/xx unknown
- 1969-07-17 FR FR6924279A patent/FR2013248A1/fr not_active Withdrawn
- 1969-07-18 BE BE736301D patent/BE736301A/xx not_active IP Right Cessation
- 1969-07-18 NL NL6911103A patent/NL6911103A/xx unknown
- 1969-07-21 GB GB36583/69A patent/GB1281719A/en not_active Expired
- 1969-07-21 CY CY793A patent/CY793A/xx unknown
-
1975
- 1975-12-30 MY MY89/75A patent/MY7500089A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY793A (en) | 1976-12-01 |
| CA920950A (en) | 1973-02-13 |
| IE33230L (en) | 1970-01-19 |
| IL32576A0 (en) | 1969-09-25 |
| BE736301A (enExample) | 1970-01-19 |
| US3594473A (en) | 1971-07-20 |
| GB1281719A (en) | 1972-07-12 |
| MY7500089A (en) | 1975-12-31 |
| IE33230B1 (en) | 1974-05-01 |
| NL6911103A (enExample) | 1970-01-21 |
| FR2013248A1 (enExample) | 1970-03-27 |
| IL32576A (en) | 1972-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69003652T2 (de) | Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. | |
| DE2827018C2 (enExample) | ||
| DE1934334C3 (de) | Wasserfreies Präparat auf Basis gesättigter Fettalkohole und Glykollösungsmittel | |
| DE69410119T2 (de) | Wasser-in-oel-lotion, die ein corticosteroid enthaelt | |
| CH656307A5 (de) | Praeparat fuer die oertliche behandlung der akne. | |
| DE69619052T2 (de) | Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung | |
| CH627652A5 (en) | Topical ointment | |
| DE2241016B2 (de) | Emulgatorkombination für Cremes vom T^p Wasser in öl sowie deren Verwendung | |
| DE3411225C2 (enExample) | ||
| DE2514873C2 (de) | Salbengrundlage | |
| DE1934969A1 (de) | Antihaemorrhoidal wirkende Praeparate zur rektalen Anwendung | |
| DE1617727A1 (de) | Badeoel | |
| DE3540175C2 (de) | Dithranolhaltige pharmazeutische Zubereitung | |
| DE1106455B (de) | Salbengrundlage | |
| DE1467929A1 (de) | Verfahren zur Herstellung von Vitamin-Praeparaten | |
| CH641042A5 (de) | Mittel zur behandlung seborrhoischer zustaende. | |
| CH647948A5 (de) | Mittel fuer die aeusserliche behandlung von wunden oder suppositorien fuer die behandlung von wunden bei menschen und tieren. | |
| EP0131790A2 (de) | Etofenamat-Zubereitung | |
| DE2401945A1 (de) | Fettgemische sowie daraus hergestellte emulsionen | |
| DE69705968T2 (de) | Zubereitung auf der basis von kokosöl und ihre verwendung | |
| DE2347243A1 (de) | Pharmazeutische zusammensetzungen | |
| DE2243281B2 (de) | Hautpflegemittel | |
| EP0383162A1 (de) | Verwendung einer Wirkstoffkombination zur Behandlung rheumatischer Erkrankungen | |
| DE69320638T2 (de) | Topisches mittel | |
| DE3020616A1 (de) | Kosmetikstiftmasse mit antiphlogistischer wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHN | Withdrawal |